Salarius Pharmaceuticals
SLRX
SLRX
35 hedge funds and large institutions have $25M invested in Salarius Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 4 closing their positions.
Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.8%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
10
Reduced
9
Closed
4
Calls
$1K
Puts
$83K
Net Calls
-$82K
Net Calls Change
-$82K
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$643K |
| 2 |
2
JPMorgan Chase & Co
New York
|
$188K |
| 3 |
3
Millennium Management
New York
|
$301K |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$1.66M |
| 5 |
VF
5
Virtu Financial
New York
|
$109K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Morgan Stanley
New York
| $20K | 4,000 | – | – |
|
|
VIA
27
Vantage Investment Advisors
State College,
Pennsylvania
| $3K | 500 | +500 | New |
|
|
MAM
28
Meeder Asset Management
Dublin,
Ohio
| $2K | 429 | -830 | -66% |
|
|
TRCT
29
Tower Research Capital (TRC)
New York
| $1K | 268 | -378 | -59% |
|
|
LTFS
30
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | 100 | – | – |
|
31
Simplex Trading
Chicago,
Illinois
| $1K | 359 | +90 | +33% |
|
32
Bank of America
Charlotte,
North Carolina
| $1K | 209 | +209 | New |
|
33
BNP Paribas Financial Markets
Paris,
France
| $35 | 7 | – | – |
|
|
SFM
34
Sphera Funds Management
Tel Aviv,
Israel
| – | – | -241,211 | Closed |
|
35
Macquarie Group
Sydney, NSW 2000,
Australia
| – | – | -5,575 | Closed |
|
36
UBS Group
Zurich,
Switzerland
| – | – | -1,925 | Closed |
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -1 | Closed |
|
38
Barclays
London,
United Kingdom
| $0 | 88 | – | – |
|
39
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $0 | 27 | – | – |
|